Last reviewed · How we verify

NCT05832242

Developing a Decision Tool for Diverticulitis in the Emergency Department Using Ultrasound

Status unknown Last updated 27 April 2023
What this trial tests

trial testing Ultrasound in Diverticulitis in 4,000 participants. Status unknown.

Timeline
28 February 2023
Primary endpoint
28 February 2025
28 February 2025

Quick facts

Lead sponsorNorthwell Health
StatusStatus unknown
Study typeOBSERVATIONAL
Enrollment4,000
Start date28 February 2023
Primary completion28 February 2025
Estimated completion28 February 2025
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

Northwell Health — full company profile →

Who can join

18 and older, any sex, with Diverticulitis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this study is to create a decision tool using ultrasound, patient history, and laboratory values to predict a diagnosis of complicated diverticulitis and whether the patient requires further imaging. The accuracy of the decision tool will be evaluated. This study will also assess the ability of ultrasound to diagnose complicated and simple diverticulitis, and the inter-provider reliability of ultrasound interpretation of diverticulitis

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Ultrasound

Trials testing the same drug.

Other recruiting trials for Diverticulitis

Currently open trials in the same condition.

Other Northwell Health trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05832242.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing